Researchers from the David Grant Medical Center, at Travis Air Force Base, in Fairfield, California, have found that oral doses of aloe vera can reduce fasting blood glucose and glycated hemoglobin (HbA1c), which indicates the average glucose level over the previous three months, in patients with Type 2 diabetes.

Data from nine clinical studies that included 89 diabetes patients were analyzed. Findings suggest that patients with a fasting blood glucose level of more than 200 milligrams per deciliter experienced the greatest benefits from the aloe vera.

This article appears in the February 2017 issue of Natural Awakenings.